<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02294539</url>
  </required_header>
  <id_info>
    <org_study_id>KSH_AMST</org_study_id>
    <nct_id>NCT02294539</nct_id>
  </id_info>
  <brief_title>Comparison of Effects Between Amlodipine and Hydrochlorothiazide in Combination With Losartan on 24-hr Central Blood Pressure in Hypertensive Patients</brief_title>
  <official_title>Comparison of Effects Between Calcium Channel Blocker and Diuretics in Combination With Angiotensin II Receptor Blocker on 24-hr Central Blood Pressure and Vascular Hemodynamic Parameters in Hypertensive Patients Multicenter, Double-blind, Active-controlled, Phase 4 Randomized Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chong-Jin Kim</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hanmi Pharmaceutical Company Limited</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Kyung Hee University Hospital at Gangdong</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate which combination therapy is more effective for
      improving the blood pressure (BP) and AM central SBP in hypertensive patients:Angiotensin II
      receptor blocker (ARB) plus calcium channel blocker (CCB) or ARB plus diuretics
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2014</start_date>
  <completion_date type="Actual">May 18, 2016</completion_date>
  <primary_completion_date type="Actual">May 18, 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change from baseline in msSBP</measure>
    <time_frame>4 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>change from baseline in AMcSBP</measure>
    <time_frame>20 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">231</enrollment>
  <condition>Hypertension</condition>
  <arm_group>
    <arm_group_label>Losartan 50mg/amlodipine 5mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Once daily, 1T, PO medication</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Losartan 100mg/amlodipine 5mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Once daily, 1T, PO medication</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Losartan50 mg/Hydrochlorothiazide12.5 mg</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Once daily, 1T, PO medication</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Losartan100 mg/Hydrochlorothiazide25 mg</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Once daily, 1T, PO medication</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Losartan 50mg/amlodipine 5mg</intervention_name>
    <description>once daily, 1T, PO medication</description>
    <arm_group_label>Losartan50 mg/Hydrochlorothiazide12.5 mg</arm_group_label>
    <other_name>amosartan 5/50mg</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Losartan 100mg/amlodipine 5mg</intervention_name>
    <description>once daily, 1T, PO medication</description>
    <arm_group_label>Losartan100 mg/Hydrochlorothiazide25 mg</arm_group_label>
    <other_name>amosartan 5/100mg</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Losartan 50mg/Hydrochlorothiazide 12.5mg</intervention_name>
    <description>once daily, 1T, PO medication</description>
    <arm_group_label>Losartan 50mg/amlodipine 5mg</arm_group_label>
    <other_name>Cozaar Plus</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Losartan 100mg/Hydrochlorothiazide 25mg</intervention_name>
    <description>once daily, 1T, PO medication</description>
    <arm_group_label>Losartan 100mg/amlodipine 5mg</arm_group_label>
    <other_name>Cozaar Plus F</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Hypertension patients not included exclusion criteria

          -  Mean seated SBP ≥140mmHg in patients with newly Diagnosed

        Exclusion Criteria:

        - msDBP≥110mmHg or ms SBP ≥ 180mmHg at the screening and randomization visit
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chong-Jin Kim</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kyung Hee University Hospital at Gangdong</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kyung Hee University Hospital at Gangdong</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 12, 2014</study_first_submitted>
  <study_first_submitted_qc>November 18, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 19, 2014</study_first_posted>
  <last_update_submitted>March 14, 2017</last_update_submitted>
  <last_update_submitted_qc>March 14, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 15, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Kyung Hee University Hospital at Gangdong</investigator_affiliation>
    <investigator_full_name>Chong-Jin Kim</investigator_full_name>
    <investigator_title>Chairman of Cardiovascular Center</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Amlodipine</mesh_term>
    <mesh_term>Losartan</mesh_term>
    <mesh_term>Hydrochlorothiazide</mesh_term>
    <mesh_term>Calcium Channel Blockers</mesh_term>
    <mesh_term>Angiotensin Receptor Antagonists</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

